Considering the complexity of clinical manifestations in C9orf72 repeat expansion carriers, further studies with larger cohorts are necessary to elucidate the potential contribution of APOE genotype, as well as ATXN1 and ATXN2 repeat lengths, to the ALS/FTD phenotype. This evidence concerns the gene C9orf72 and frontotemporal dementia.